while in the rapidly evolving discipline of oncology investigation, accurate and effective mutation screening is vital for building specific therapies. The KRAS solutions System performs a pivotal purpose On this landscape by supplying in depth options for KRAS mutation profiling and Investigation. KRAS mutations, found in about 95% of RAS-relevant